Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Dermatologic 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Ovarian Neoplasms 513Uterine Cervical Neoplasms 366Endometrial Neoplasms 311Breast Neoplasms 131Colorectal Neoplasms 116Neoplasms 98Fallopian Tube Neoplasms 90Carcinoma, Non-Small-Cell Lung 88Stomach Neoplasms 85Pancreatic Neoplasms 81Lung Neoplasms 73Prostatic Neoplasms 69Melanoma 68Carcinoma, Ovarian Epithelial 66Neoplasm Metastasis 62Triple Negative Breast Neoplasms 52Vulvar Neoplasms 50Squamous Cell Carcinoma of Head and Neck 49Head and Neck Neoplasms 45Esophageal Neoplasms 44Peritoneal Neoplasms 41Uterine Neoplasms 40Urinary Bladder Neoplasms 40Carcinoma, Hepatocellular 35Carcinoma, Renal Cell 34Papillomavirus Infections 33Uterine Cervical Dysplasia 31Colonic Neoplasms 31Sarcoma 30Vaginal Neoplasms 28

Interventions

Loperamide 1Fecal Microbiota Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Colitis × Gynecologic × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡